Although previous studies reported increased CSF soluble TREM2 (sTREM2) in different clinical stages of Alzheimer’s disease, the exact association between Alzheimer’s disease hallmarks such as amyloid-beta and tau pathology remains unclear. The gene discussed is MAPT; the disease is Alzheimer disease.